TARA Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 mai 2024 @ 22:00):

Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases...

Stats
Dagens volum	134 286
Gjennomsnittsvolum	282 874
Markedsverdi	33.27M
EPS	$0 ( 2024-05-02 )
Neste inntjeningsdato	( $-0.810 ) 2024-08-01
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.820
ATR14	$0.0180 (0.62%)

Insider Trading

Date	Person	Action	Amount	type
2024-01-19	Shefferman Jesse	Buy	59 000	Common Stock
2024-01-19	Shefferman Jesse	Sell	7 803	Common Stock
2024-01-19	Shefferman Jesse	Buy	357 000	Stock Option (Right to Buy)
2024-01-19	Bandari Jathin	Buy	137 000	Stock Option (Right to Buy)
2024-01-19	Bandari Jathin	Buy	23 000	Common Stock

INSIDER POWER
91.93
Last 95 transactions
Buy: 2 372 974 \| Sell: 114 915

Volum Korrelasjon

Lang: 0.13 (neutral)

Kort: -0.84 (strong negative)

Signal:(43.165) Neutral

Protara Therapeutics Inc Korrelasjon

10 Mest positive korrelasjoner
PXLW	0.933
SRTS	0.925
KTCC	0.915
IMNM	0.908
LXRX	0.907
FWRG	0.905
KYMR	0.903
SWTX	0.897
COHR	0.892
NWSA	0.892

10 Mest negative korrelasjoner
RTPY	-0.921
RMRM	-0.872
KVSB	-0.863
DSWL	-0.86
SGML	-0.857
VALN	-0.857
SRNGW	-0.856
BFRI	-0.856
BSGM	-0.854
BIOL	-0.853

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Protara Therapeutics Inc Korrelasjon - Valuta/Råvare

-0.21
( neutral )

-0.48
( neutral )

0.00
( neutral )

-0.41
( neutral )

0.35
( neutral )

0.47
( neutral )

Protara Therapeutics Inc Økonomi

Annual	2023
Omsetning:	$0
Bruttogevinst:	$-341 000 (0.00 %)
EPS:	$-3.57

FY	2023
Omsetning:	$0
Bruttogevinst:	$-341 000 (0.00 %)
EPS:	$-3.57

FY	2022
Omsetning:	$0
Bruttogevinst:	$-247 000 (0.00 %)
EPS:	$-5.76

FY	2021
Omsetning:	$0.00
Bruttogevinst:	$0.00 (0.00 %)
EPS:	$-6.53

Financial Reports:

No articles found.

Protara Therapeutics Inc

Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chloride, an investigational phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease. The company was formerly known as ArTara Therapeutics, Inc. and changed its name to Protara Therapeutics, Inc. in May 2020. Protara Therapeutics, Inc. is headquartered in New York, New York.